Literature DB >> 27598297

miR-126 affects the invasion and migration of glioma cells through GATA4.

Yifan Xu1, Wu Xu1, Tianyu Lu1, Yuxiang Dai1, Weibang Liang1.   

Abstract

We aimed to explore the relationship between miR-126 and glioma. miR-126 was highly expressed in low-grade clinical glioma tissue samples but lowly expressed in high-grade ones (P < .01). A human endogenous miR-126 expression vector was constructed. The migration capacity of cells transfected with the vector significantly decreased (P < .05). Up-regulation of miR-126 suppressed GATA4 protein expression. After transfection, they slightly contracted and became ovally or spherically shaped. F-actin significantly reduced, and microfilaments shortened or disappeared. The number of membrane-penetrating cells significantly decreased (P < .01). miR-126 inhibits the migration and invasion of glioma cells, which may be linked to GATA4 as a target gene.

Entities:  

Keywords:  GATA4; glioma; invasion; miR-126

Mesh:

Substances:

Year:  2016        PMID: 27598297     DOI: 10.1080/21691401.2016.1226179

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  3 in total

1.  Linc01094 Accelerates the Growth and Metastatic-Related Traits of Glioblastoma by Sponging miR-126-5p.

Authors:  Xin Xing Li; Qi Yu
Journal:  Onco Targets Ther       Date:  2020-10-06       Impact factor: 4.147

2.  EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors.

Authors:  Nevenka Dudvarski Stanković; Frank Bicker; Stefanie Keller; David Tw Jones; Patrick N Harter; Arne Kienzle; Clarissa Gillmann; Philipp Arnold; Anna Golebiewska; Olivier Keunen; Alf Giese; Andreas von Deimling; Tobias Bäuerle; Simone P Niclou; Michel Mittelbronn; Weilan Ye; Stefan M Pfister; Mirko H Schmidt
Journal:  EMBO Mol Med       Date:  2018-09       Impact factor: 12.137

3.  The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.

Authors:  Jiqin Xu; Hongyun Wang; Huiyan Wang; Qing Chen; Li Zhang; Chao Song; Qianqian Zhou; Ying Hong
Journal:  Hereditas       Date:  2019-04-09       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.